State Street’s Kiromic BioPharma, Inc. Common Stock KRBP Stock Holding History

State Street’s Portfolio KRBP Stock Details KRBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-566	Closed	-$3.06K	–	4867
2022 Q4	$3.06K	Hold	566	–	–	﹤0.01%	4846
2022 Q3	$5K	Buy	566 +10	+2%	+$116	﹤0.01%	4917
2022 Q2	$7K	Hold	556	–	–	﹤0.01%	4935
2022 Q1	$14K	Hold	556	–	–	﹤0.01%	4902
2021 Q4	$26K	Hold	556	–	–	﹤0.01%	4765
2021 Q3	$51K	Buy	+556	New	+$57.5K	﹤0.01%	4640

Other funds holding KRBP

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street's KRBP Position: Q1 2023 in Review

State Street sold out of Kiromic BioPharma, Inc. Common Stock (KRBP) in Q1 2023, closing a stake of 566 shares — an estimated $3.06K sold.

State Street first reported a position in KRBP in Q3 2021 and held it in 6 quarters. The position peaked at $51K in Q3 2021. 7 funds tracked by Wall St. Rank hold KRBP as of Q1 2023.

State Street reported no remaining Kiromic BioPharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
State Street sold 566 Kiromic BioPharma, Inc. Common Stock shares in Q1 2023, an estimated $3.06K.
State Street first reported a position in Kiromic BioPharma, Inc. Common Stock in Q3 2021 and held it in 6 quarters.
State Street's Kiromic BioPharma, Inc. Common Stock position peaked at $51K in Q3 2021.
7 funds tracked by Wall St. Rank held Kiromic BioPharma, Inc. Common Stock as of Q1 2023.

Based on State Street's 13F filing for Q1 2023, filed 15 May 2023.